CD28 and systemic lupus erythematosus: To examine the effect of inhibiting glycolysis on EZH2 expression, naïve CD4+ T cells isolated from SLE patients were stimulated with anti-CD3/anti-CD28 in the presence or absence of glycolysis inhibitor 2-DG.